Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wallis

Showing results (461-470 of 476) with videos related to

Pageof 48
Sort By:
BMJ Open|November 11, 2022
Optimisation of treatments for oral <i>Neisseria gonorrhoeae</i> infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trialFabian Y S Kong, Magnus Unemo, Shueh H Lim, et al.
Clinical Pharmacokinetics|March 7, 2022
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
BMJ Open|May 11, 2021
Barriers-enablers-ownership approach: a mixed methods analysis of a social intervention to improve surgical antibiotic prescribing in hospitalsJennifer Broom, Alex Broom, Chris Anstey, et al.
BMC Anesthesiology|November 30, 2012
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMOKiran Shekar, Jason A Roberts, Susan Welch, et al.
Clinical Pharmacokinetics|April 22, 2025
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19Darren M Roberts, Xin Liu, Suzanne L Parker, et al.
BMJ Open|May 17, 2018
Integrated versus nOn-integrated Peripheral inTravenous catheter. Which Is the most effective systeM for peripheral intravenoUs catheter Management? (The OPTIMUM study): a randomised controlled trial protocolMaria Isabel Castillo, Emily Larsen, Marie Cooke, et al.
BMJ Open|February 5, 2015
Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial)Claire M Rickard, Nicole M Marsh, Joan Webster, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2026
Population pharmacokinetics of meropenem in critically ill adult patients receiving extracorporeal membrane oxygenation-an ASAP ECMO studyMohd H Abdul-Aziz, Vesa Cheng, Fay Burrows, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO StudyVesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Pageof 48

Showing results (461-470 of 476) with videos related to

Sort By:
Pageof 48
BMJ Open|November 11, 2022
Optimisation of treatments for oral <i>Neisseria gonorrhoeae</i> infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trialFabian Y S Kong, Magnus Unemo, Shueh H Lim, et al.
Clinical Pharmacokinetics|March 7, 2022
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)Vesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
BMJ Open|May 11, 2021
Barriers-enablers-ownership approach: a mixed methods analysis of a social intervention to improve surgical antibiotic prescribing in hospitalsJennifer Broom, Alex Broom, Chris Anstey, et al.
BMC Anesthesiology|November 30, 2012
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMOKiran Shekar, Jason A Roberts, Susan Welch, et al.
Clinical Pharmacokinetics|April 22, 2025
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19Darren M Roberts, Xin Liu, Suzanne L Parker, et al.
BMJ Open|May 17, 2018
Integrated versus nOn-integrated Peripheral inTravenous catheter. Which Is the most effective systeM for peripheral intravenoUs catheter Management? (The OPTIMUM study): a randomised controlled trial protocolMaria Isabel Castillo, Emily Larsen, Marie Cooke, et al.
BMJ Open|February 5, 2015
Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial)Claire M Rickard, Nicole M Marsh, Joan Webster, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2023
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO studyEmmanuel Novy, Mohd H Abdul-Aziz, Vesa Cheng, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2026
Population pharmacokinetics of meropenem in critically ill adult patients receiving extracorporeal membrane oxygenation-an ASAP ECMO studyMohd H Abdul-Aziz, Vesa Cheng, Fay Burrows, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO StudyVesa Cheng, Mohd H Abdul-Aziz, Fay Burrows, et al.
Pageof 48